Felix Baker

Director, NEUROGEN CORP.

Companies

Denali Therapeutics Inc.Board member Jun 5, 2025 to now¹
Replimune Group, Inc.Board member Mar 7, 2025 to now²
ImmunocoreBoard member May 29, 2024 to now³
Bicycle Therapeutics (United Kingdom)Board member Apr 18, 2024 to now⁴
Kymera TherapeuticsBoard member Apr 1, 2024 to now⁵
vTv Therapeutics Inc.Board member Mar 7, 2024 to now⁶
MADRIGAL PHARMACEUTICALS, INC.Board member Jun 20, 2023 to now⁷
TScan Therapeutics, Inc.Board member Jul 15, 2021 to now⁸
DBV TechnologiesBoard member Jan 11, 2021 to now⁹
Prelude Therapeutics IncBoard member Sep 24, 2020 to now¹⁰
IGM Biosciences, Inc.Board member Sep 17, 2019 to now¹¹
Kodiak Sciences Inc.Board member Oct 3, 2018 to now¹²
Kiniksa Pharmaceuticals International, plcBoard member May 23, 2018 to now¹³
BeOne Medicines Ltd.Board member Feb 2, 2016 to now¹⁴
Acadia PharmaceuticalsBoard member Jan 23, 2013 to now¹⁵
IncyteBoard member Jan 8, 2008 to now¹⁶
Neurogene Inc.Board member May 9, 2017 to Dec 20, 2023¹⁷
SeagenBoard member Apr 28, 2006 to Dec 18, 2023¹⁸
Talis Biomedical CorpBoard member Feb 11, 2021 to Jun 13, 2023¹⁹
Aeglea BioTherapeuticsBoard member Feb 25, 2021 to Jun 10, 2021²⁰
Alexion PharmaceuticalsBoard member Jun 24, 2015 to May 18, 2020²¹
ZymeworksBoard member Mar 16, 2020 to May 12, 2020²²
Genomic HealthBoard member Mar 13, 2007 to Oct 3, 2019²³
Idera SoftwareBoard member Mar 12, 2014 to Apr 3, 2019²⁴
XOMA Royalty CorpBoard member Oct 31, 2012 to Jan 6, 2015²⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kodiak Sciences Inc. KOD15,455,507 shares²⁶$1.4B at $92.59May 27, 2022
Kymera Therapeutics KYMR7,955,916 shares²⁷$859.4M at $108.02Dec 11, 2025
MADRIGAL PHARMACEUTICALS, INC. MDGL1,859,091 shares²⁸$827.5M at $445.11Aug 18, 2025
Acadia Pharmaceuticals ACAD38,587,857 shares²⁹$756.7M at $19.61Jan 17, 2023
Replimune Group, Inc. REPL10,116,095 shares³⁰$111.2M at $10.99Mar 7, 2025
Bicycle Therapeutics (United Kingdom) BCYC10,018,674 shares³¹$36.4M at $3.63Jan 2, 2026
Incyte INCY314,600 shares³²$35.8M at $113.77Jul 2, 2026
Seagen SGEN42,988,281 shares³³Mar 10, 2022
IGM Biosciences, Inc.2,896,968 shares³⁴Sep 29, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2026Granted 400 shares of Incyte³²
Jun 30, 2026Granted 400 shares of Incyte³²
Jan 2, 2026Granted 19,000 shares of Bicycle Therapeutics (United Kingdom)³¹
Jan 2, 2026Granted 19,000 shares of Bicycle Therapeutics (United Kingdom)³¹
Dec 31, 2025Granted 328 shares of Incyte³⁵
Dec 31, 2025Granted 328 shares of Incyte³⁵
Dec 11, 2025Bought 1,838,621 shares at $86.00 of Kymera Therapeutics²⁷
Dec 11, 2025Bought 167,192 shares at $86.00 of Kymera Therapeutics²⁷
Nov 20, 2025Bought 13,082 shares at $9.07 of Entrada Therapeutics, Inc.³⁶
Nov 20, 2025Bought 1,186 shares at $9.07 of Entrada Therapeutics, Inc.³⁶
Nov 20, 2025Bought 13,386 shares at $9.07 of Entrada Therapeutics, Inc.³⁶
Nov 20, 2025Bought 1,213 shares at $9.07 of Entrada Therapeutics, Inc.³⁶
Sep 30, 2025Granted 388 shares of Incyte³⁷
Sep 30, 2025Granted 388 shares of Incyte³⁷
Aug 18, 2025Bought 10,128 shares at $372.16 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 933 shares at $372.16 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 5,494 shares at $371.01 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 506 shares at $371.01 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 2,747 shares at $369.34 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 253 shares at $369.34 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 1,419 shares at $368.84 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 131 shares at $368.84 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 4,798 shares at $367.77 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 442 shares at $367.77 of MADRIGAL PHARMACEUTICALS, INC.²⁸
Aug 18, 2025Bought 2,289 shares at $366.30 of MADRIGAL PHARMACEUTICALS, INC.²⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARDenali Therapeutics Inc., Board member
2
SEC EDGARReplimune Group, Inc., Board member
3
SEC EDGARImmunocore, Board member
4
SEC EDGARBicycle Therapeutics (United Kingdom), Board member
5
SEC EDGARKymera Therapeutics, Board member
6
SEC EDGARvTv Therapeutics Inc., Board member
7
SEC EDGARMADRIGAL PHARMACEUTICALS, INC., Board member
8
SEC EDGARTScan Therapeutics, Inc., Board member
9
SEC EDGARDBV Technologies, Board member
10
SEC EDGARPrelude Therapeutics Inc, Board member
11
SEC EDGARIGM Biosciences, Inc., Board member
12
SEC EDGARKodiak Sciences Inc., Board member
13
SEC EDGARKiniksa Pharmaceuticals International, plc, Board member
14
SEC EDGARBeOne Medicines Ltd., Board member
15
SEC EDGARAcadia Pharmaceuticals, Board member
16
SEC EDGARIncyte, Board member
17
SEC EDGARNeurogene Inc., Board member
18
SEC EDGARSeagen, Board member
19
SEC EDGARTalis Biomedical Corp, Board member
20
SEC EDGARAeglea BioTherapeutics, Board member
21
SEC EDGARAlexion Pharmaceuticals, Board member
22
SEC EDGARZymeworks, Board member
23
SEC EDGARGenomic Health, Board member
24
SEC EDGARIdera Software, Board member
25
SEC EDGARXOMA Royalty Corp, Board member
26
SEC EDGARKodiak Sciences Inc. shares after the filing of May 27, 2022
27
SEC EDGARKymera Therapeutics shares after the filing of Dec 11, 2025
28
SEC EDGARMADRIGAL PHARMACEUTICALS, INC. shares after the filing of Aug 18, 2025
29
SEC EDGARAcadia Pharmaceuticals shares after the filing of Jan 17, 2023
30
SEC EDGARReplimune Group, Inc. shares after the filing of Mar 7, 2025
31
SEC EDGARBicycle Therapeutics (United Kingdom) shares after the filing of Jan 2, 2026
32
SEC EDGARIncyte shares after the filing of Jul 2, 2026
33
SEC EDGARSeagen shares after the filing of Mar 10, 2022
34
SEC EDGARIGM Biosciences, Inc. shares after the filing of Sep 29, 2023
35
SEC EDGARForm 4 filed Jan 5, 2026
36
SEC EDGARForm 4 filed Nov 24, 2025
37
SEC EDGARForm 4 filed Oct 2, 2025